Fixed-dose combination therapy (polypill) for the prevention of cardiovascular disease

JAMA - Journal of the American Medical Association

Volumn 312, Issue 19, 2014, Pages 2030-2031

  Huffman, Mark D ^a   De Cates, Angharad N ^b   Ebrahim, Shah ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CHOLESTEROL; PLACEBO; POLYPILL; UNCLASSIFIED DRUG; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR RISK; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; COUGHING; DRUG EFFICACY; DRUG SAFETY; FIXED DOSE COMBINATION THERAPY; HEART PROTECTION; HUMAN; HYPERTENSION; MYALGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; CARDIOVASCULAR DISEASES;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CARDIOVASCULAR DISEASES; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 84929141893     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.13616     Document Type: Short Survey

References (6)

1. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance. Am J Med. 2007;120(8): 713-719.
2. de Cates AN, Farr MR, Wright N, et al. Fixed-dose combination therapy for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;4:CD009868.
3. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE. BMJ. 2008;336(7650): 924-926.
4. Thom S, Poulter N, Field J, et al; UMPIRE Collaborative Group. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD [published correction appears in JAMA. 2013;310(14):1507]. JAMA. 2013;310(9):918-929.
5. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA. 2014;311(5): 507-520.
6. Huffman MD, Yusuf S. Polypills: essential medicines for cardiovascular disease secondary prevention? J Am Coll Cardiol. 2014;63(14):1368-1370.